<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font30">and </span>
   <span class="font18">[]. </span>
   <span class="font18">with </span>
   <span class="font16">for </span>
   <span class="font13">;():â€". </span>
   <span class="font13">al. </span>
   <span class="font13">{background </span>
   <span class="font13">patients </span>
   <span class="font12">NCT </span>
   <span class="font12">has </span>
   <span class="font12">that </span>
   <span class="font12">treatment </span>
   <span class="font12">drugs </span>
   <span class="font12">margin </span>
   <span class="font12">COVID- </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">{border-style </span>
   <span class="font12">been </span>
   <span class="font12">clinical </span>
   <span class="font12">viral </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">drug </span>
   <span class="font12">cardiovascular </span>
   <span class="font12">have </span>
   <span class="font12">was </span>
   <span class="font11">its </span>
   <span class="font11">RNA </span>
   <span class="font11">The </span>
   <span class="font11">also </span>
   <span class="font11">Cardiovascular </span>
   <span class="font11">effects </span>
   <span class="font11">potential </span>
   <span class="font11">are </span>
   <span class="font11">coronavirus </span>
   <span class="font11">effect </span>
   <span class="font11">interval </span>
   <span class="font11">trial </span>
   <span class="font11">virus, </span>
   <span class="font11">Mechanisms </span>
   <span class="font11">may </span>
   <span class="font11">prolongation </span>
   <span class="font11">;:. </span>
   <span class="font11">Drug </span>
   <span class="font11">HCQ </span>
   <span class="font11">HIV </span>
   <span class="font11">Interactions </span>
   <span class="font11">Risks </span>
   <span class="font11">inhibitor </span>
   <span class="font11">replication </span>
   <span class="font11">study </span>
   <span class="font11">treating </span>
   <span class="font11">CYPA </span>
   <span class="font11">However, </span>
   <span class="font11">against </span>
   <span class="font11">antiviral </span>
   <span class="font11">approved </span>
   <span class="font11">cytochrome </span>
   <span class="font11">disease </span>
   <span class="font11">efficacy </span>
   <span class="font11">fingolimod </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">including </span>
   <span class="font11">metabolized </span>
   <span class="font11">therapeutic </span>
   <span class="font11">this </span>
   <span class="font11">trials </span>
   <span class="font11">virus </span>
   <span class="font11">Clin </span>
   <span class="font11">Clinical </span>
   <span class="font11">Medicine, </span>
   <span class="font11">QTc </span>
   <span class="font11">[], </span>
   <span class="font11">case </span>
   <span class="font11">during </span>
   <span class="font11">ivermectin </span>
   <span class="font11">polymerase </span>
   <span class="font11">protease </span>
   <span class="font11">px; </span>
   <span class="font11">reported </span>
   <span class="font11">tocilizumab </span>
   <span class="font11">were </span>
   <span class="font11">{font-family </span>
   <span class="font10">;:â€". </span>
   <span class="font10">CYPA, </span>
   <span class="font10">CYPC, </span>
   <span class="font10">Dis. </span>
   <span class="font10">Drugs </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">activity </span>
   <span class="font10">agents </span>
   <span class="font10">anti-SARS-CoV- </span>
   <span class="font10">font-size </span>
   <span class="font10">interactions </span>
   <span class="font10">multiple </span>
   <span class="font10">open-label </span>
   <span class="font10">remdesivir </span>
   <span class="font10">results </span>
   <span class="font10">review </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">such </span>
   <span class="font10">used </span>
   <span class="font10">vitro </span>
   <span class="font10">Cheng </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">Liu </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">SARS </span>
   <span class="font10">Wang </span>
   <span class="font10">but </span>
   <span class="font10">combined </span>
   <span class="font10">current </span>
   <span class="font10">double; </span>
   <span class="font10">effective </span>
   <span class="font10">evaluate </span>
   <span class="font10">favipiravir </span>
   <span class="font10">increase </span>
   <span class="font10">infection </span>
   <span class="font10">inhibitors </span>
   <span class="font10">interaction </span>
   <span class="font10">interferon </span>
   <span class="font10">novel </span>
   <span class="font10">primarily </span>
   <span class="font10">severe </span>
   <span class="font10">significant </span>
   <span class="font10">substrate </span>
   <span class="font10">therapy </span>
   <span class="font10">these </span>
   <span class="font10">through </span>
   <span class="font10">yet </span>
   <span class="font10">â€" </span>
   <span class="font10">;():e. </span>
   <span class="font10">Although </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Department </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Fingolimod </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">JM, </span>
   <span class="font10">Liver </span>
   <span class="font10">Med </span>
   <span class="font10">Res. </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">active </span>
   <span class="font10">arthritis </span>
   <span class="font10">atazanavir </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">cardiac </span>
   <span class="font10">combination </span>
   <span class="font10">compared </span>
   <span class="font10">concentrations </span>
   <span class="font10">copy </span>
   <span class="font10">cytokine </span>
   <span class="font10">immune </span>
   <span class="font10">inhibition </span>
   <span class="font10">into </span>
   <span class="font10">metabolism </span>
   <span class="font10">mortality </span>
   <span class="font10">non-randomized </span>
   <span class="font10">not </span>
   <span class="font10">one </span>
   <span class="font10">pneumonia </span>
   <span class="font10">randomized </span>
   <span class="font10">rapid </span>
   <span class="font10">report </span>
   <span class="font10">reports </span>
   <span class="font10">respiratory </span>
   <span class="font10">ribavirin </span>
   <span class="font10">ritonavir/lopinavir </span>
   <span class="font10">safety </span>
   <span class="font10">showed </span>
   <span class="font10">solid; </span>
   <span class="font10">those </span>
   <span class="font10">toxicity </span>
   <span class="font10">use </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(%) </span>
   <span class="font10">;():. </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Antivir </span>
   <span class="font10">April </span>
   <span class="font10">China </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Heart </span>
   <span class="font10">III </span>
   <span class="font10">IL- </span>
   <span class="font10">Int </span>
   <span class="font10">MERS </span>
   <span class="font10">Med. </span>
   <span class="font10">Medical </span>
   <span class="font10">Most </span>
   <span class="font10">OATPB </span>
   <span class="font10">PLoS </span>
   <span class="font10">RSV </span>
   <span class="font10">Ritonavir/lopinavir </span>
   <span class="font10">SARS-CoV-; </span>
   <span class="font10">This </span>
   <span class="font10">Trop </span>
   <span class="font10">among </span>
   <span class="font10">anti-COVID- </span>
   <span class="font10">atrioventricular </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">called </span>
   <span class="font10">cardiotoxicity </span>
   <span class="font10">cause </span>
   <span class="font10">cell </span>
   <span class="font10">cells </span>
   <span class="font10">cells, </span>
   <span class="font10">clinically </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">dose </span>
   <span class="font10">em; </span>
   <span class="font10">from </span>
   <span class="font10">grid.. </span>
   <span class="font10">healthy </span>
   <span class="font10">heart </span>
   <span class="font10">higher </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibits </span>
   <span class="font10">involved </span>
   <span class="font10">ion </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">mechanism </span>
   <span class="font10">number </span>
   <span class="font10">observed </span>
   <span class="font10">ongoing </span>
   <span class="font10">oral </span>
   <span class="font10">other </span>
   <span class="font10">potent </span>
   <span class="font10">proteins </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor </span>
   <span class="font10">regimens </span>
   <span class="font10">ribavirin. </span>
   <span class="font10">risks </span>
   <span class="font10">serum </span>
   <span class="font10">several </span>
   <span class="font10">should </span>
   <span class="font10">shown </span>
   <span class="font10">site </span>
   <span class="font10">there </span>
   <span class="font10">treat </span>
   <span class="font10">ventricular </span>
   <span class="font10">warfarin </span>
   <span class="font10">who </span>
  </p>
 </body>
</html>
